# Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption

> **NCT02371473** · PHASE4 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 12 (estimated)

## Conditions studied

- Central Sleep Apnea, Secondary

## Interventions

- **DRUG:** Acetazolamide-placebo
- **DRUG:** Placebo-acetazolamide

## Key facts

- **NCT ID:** NCT02371473
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2018-06
- **Final completion:** 2018-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02371473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02371473, "Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02371473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*